Significant boardmember joins mycoTeQ

News RSS feed

Investment in promising method for treatment of chronical diabetes foot ulcers

(02.09.2010) The Danish company Reapplix has developed the product LeucoPatch ™ for treatment of severe chronic foot ulcers. The prod...
Read more

SEED Capital has invested in 11 new growth companies in first 2 quarters of 2010

(6.07.2010) In a time of crisis with far between the positive stories, and with banks and investors keeping a lid on spending, the venture...
Read more

Nangate on Red Herrings hot list

(28.5.2010) Nangate has been listed on Red Herring's list of the top 100 most innovative companies in Europe in 2010. Red Her...
Read more

How we work with business proposals

Out of more than 400 business proposals presented each year, DSI invests in up to 15 new companies. DSI evaluates all proposals in se...
Read more

Significant boardmember joins mycoTeQ

(28.2.2007) R&D Executive Vice President and Chairman of the Board for LEO Pharma, Poul Rasmussen, joins the board of the young biotech company MycoTeQ. The company has access to a comprehensive library of microfungi that includes more than 30,000 unique strains. Poul Rasmussen says:"There must be a lot of interesting molecules in that fungal collection."

Read article in Børsen (February 28 2007) Løve går på svampejagt

Please visit our portfolio description of MycoTeQ

Web: www.mycoteq.com

For Further information please Contact.

Frank Knudsen, Investment Manager

fk@seedcapital.dk

Phone: +45 39179412

(Published 28 February)